Your session is about to expire
← Back to Search
Procedure
Stimulation On for Neuropathic Pain (SPARK Trial)
N/A
Waitlist Available
Led By Lutz Weise, MD, PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of post intra-thoracic surgery pain syndrome
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at 4, 10, 16, 26, and 52 weeks post-surgery
Awards & highlights
SPARK Trial Summary
This trial will test if spinal cord stimulation is effective in treating pain in patients who have had thoracic surgery.
What is being tested?
This study is looking at how well spinal cord stimulation helps with pain after chest surgery. It's a controlled trial where patients are randomly chosen to receive either the real treatment or a placebo, and then they switch.See study design
SPARK Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have pain after chest surgery.
SPARK Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and at 4, 10, 16, 26, and 52 weeks post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at 4, 10, 16, 26, and 52 weeks post-surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline on the Numerical Rating Scale (NRS) for pain intensity
Secondary outcome measures
Change in morphine equivalents used
Change in score on EuroQol 5 Dimension Questionnaire
Change in score on Oswestry Disability Index
+2 moreSide effects data
From 2019 Phase 4 trial • 30 Patients • NCT0328441110%
Device stimulation issue
3%
Inadequate analgesia
3%
Back pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Spinal Cord Stimulation
SPARK Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Stimulation OnExperimental Treatment1 Intervention
Spinal cord stimulators will be optimized to each participant and then programmed to deliver high frequency stimulation below detectable threshold for 6 weeks.
Group II: Stimulation OffPlacebo Group1 Intervention
Spinal cord stimulators will be optimized to each participant as in the experimental arm, and then programmed to deliver no stimulation for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal Cord Stimulation
2020
Completed Phase 4
~90
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
260 Previous Clinical Trials
83,898 Total Patients Enrolled
1 Trials studying Neuropathic Pain
12 Patients Enrolled for Neuropathic Pain
Lutz Weise, MD, PhDPrincipal InvestigatorNova Scotia Health Authority
1 Previous Clinical Trials
40 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available for patients to participate in this trial?
"Per the information provided on clinicaltrials.gov, this specific research study is not presently seeking new participants. The trial was first published on June 1st, 2024 and underwent its most recent update on April 25th, 2024. Although recruitment has ceased for this particular trial, it's worth noting that there are currently 602 other trials actively enrolling patients at present."
Answered by AI
Share this study with friends
Copy Link
Messenger